Both in Pharmaceuticals
Praxis Precision Medicines vs Cytokinetics
Over the past year PRAX returned +54.1% and CYTK returned +3.8%; their daily moves had a correlation of 0.28.
PRAX +54.1% CYTK +3.8%Growth of $1, one year, split-adjusted
| Metric | PRAX | CYTK |
|---|---|---|
| Price | $280.51 | $62.31 |
| Market cap | $7.83B | $8.66B |
| Today | +2.38% | +0.45% |
| 1 month | −1.1% | −0.6% |
| 6 months | −15.8% | −19.2% |
| Year to date | −4.8% | −1.9% |
| 1 year | +41.1% | −2.0% |
| Revenue growth (YoY) | — | −57.1% |
| Gross margin | — | 90.5% |
| Net margin | — | −694.4% |
| P/E (TTM) | — | — |
| Price / sales | — | 128.0× |
| Net cash | $758.6M | $18.6M |
| Dividend yield | — | — |
| Volatility (60d) | 48.5% | 31.7% |
| Short % of float | 14.1% | 15.4% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).